Tricholoma caligatum (Viv.) Ricken is an edible mushroom that belongs to matsutake group. The first chemical investigation of the three different extracts of Tricholoma caligatum resulted in two new compounds, 8-demethoxylascivol (1) and 8-epi-lascivol (2) and six known compounds, lascivol (3), trametenolic acid (4), ergosterol (5), ergosterol peroxide (6), 5, 6-epoxyergosterol (7), and cerebroside B (8). Their structures were elucidated by spectroscopic analyses including 1D and 2D NMR data. The biological activities of all the compounds were evaluated toward multiple targets related to inflammation and metabolic disorder such as NF-κΒ, iNOS and ROS. The findings of this study reveal that the edible mushroom Tricholoma caligatum could be a potential source for anti-inflammatory bioactive metabolites.
Introduction
Tricholoma matsutake (pine mushroom) is a highly valuable commercial mushroom, particularly in the Asian countries due to the medicinal properties. It has been used as a traditional medicine in China since ancient times [1] . The literature survey indicates that polysaccharides, steroids [2] [3] and many miscellaneous compounds exhibiting antioxidant, antitumor, antiinflammatory [4] [5] activities have been isolated from the fruiting body. T. matsutake and several closely related species, including T. caligatum (Viv.) Ricken and T. magnivelare (Peck) Redhead were exported to Japan from Morocco, Algeria, Korea, China, North America and North Africa [6] [7] in beginning of the 21 st century. Then the North African matsutake was recognized as T. caligatum (Viv.) Ricken which has also been consumed by the local populations [7] . Inflammation is considered as a risk factor for several types of cancer, as well as a contributing factor in obesity and in metabolic disorders. NF-κB, iNOS and ROS have been considered as important targets for inflammation [8] [9] .
T. caligatum (Viv.) Ricken is a kind of the pine forest mushroom, grows especially under Pinus, Abies and Picea species during autumn. Up to date, the antioxidant and antimicrobial activities [10] and the volatile and flavored compounds of T. caligatum were studied [11] . Herein, it was aimed to isolate the secondary metabolites of T. caligatum and evaluate their potential antioxidant and antiinflammatory activities.
Materials and Methods

General Experiment Procedures
Optical rotations were recorded by AUTOPOL IV automatic polarimeter. UV spectra were recorded by a Thermo Scientific Evolution 201 UV-Visible Spectrophotometer; while, IR spectra were acquired using Agilent Technologies Cary 630 FTIR. NMR data were acquired using Bruker AU III 400 and 500, MHz NMR spectrometer HRESIMS data were obtained on an Agilent Technologies 6200 series mass spectrometer. Semi-preparative HPLC separation was performed on a Waters 27905 HPLC system equipped with a Waters 996 Photodiode Array Detector and Phenomenex C18 column (Gemini®5 µm C18 110 Å, LC Column 250 x 21.2 mm, AXIA™ Packed. All NMR solvents were obtained from Cambridge Isotope Laboratories.
Mushroom Material
The T. caligatum was collected in October 2014 from Mugla, Turkey. A voucher specimen has been deposited in the Department of Biology, Mugla Sitki Kocman University with accession number AT-1838.
Extraction and Isolation
The shade dried and pulverized mushrooms (450.7 g) were extracted successively with petroleum ether (10 × 1.5 L × 24 h), acetone (10 × 1.5 L × 24 h), and methanol (10 × 1.5 L × 24 h) at room temperature to yield TC1 (12.0 g), TC2 (10.3), and TC3 (50.1 g) extracts, respectively, after removal of solvents under reduced pressure. The methanol extract (TC3, 47.0 g) was applied to column chromatography (CC) over Diaion HP-20 resin (40 cm × 6.5 cm) using gradients of H2O: MeOH (100:0-50:50-0:100) to afford 21 fractions (TC31-TC321). Fr. TC37 was re-chromatographed on a silica gel column (90 cm × 5 cm) using a mixture of CHCI3: MeOH: H2O (8:2:0.25) to afford 20 sub-fractions (TC37a-TC37t). Compounds 1 (2.6 mg, tR=32.7), 2 (2.3 mg, tR=34.5), and 3 (4.5 mg, tR=35.5) were purified from sub-fraction Fr. TC37s by HPLC using C18 column (Gemini®5 µm C18 110 Å, 250 mm × 21.2 mm) with gradients of MeOH (A) and H2O (B) at a flow rate of 3.0 mL/min, with 20% A (0-10 min), increased 30% A (at 10-20 min), increased 50% A (at 20-25 min), increased 100% A (at 25-35 min), and remained constant at 100% at 35-60 min. Compound 5 (438.0 mg) was purified along with eighteen fractions (TC11-TC120) from TC1 (11.0 g) by CC over silica gel (90 cm × 4 cm) eluted with gradients of hexanes: EtOAc (100:0 to 0:100). Fr. TC12 (342.0 mg) was applied to CC [silica gel (50 cm × 2 cm), hexanes: EtOAc (3:1)] to yield 4 (19.0 mg). Compound 6 (15.1 mg) was purified from Fr. TC19 (464.1 mg) by CC on silica gel (60 cm × 2 cm) with hexanes: EtOAc (3:1) as elution system. TC2 (9.5 g) was fractionated by CC on silica gel (100 cm × 4 cm) using gradient elution (hexanes: chloroform (100:0 to 0:100), then acetone and methanol) to generate 24 fractions (TC21-TC224). Compounds 7 (4.1 mg) from TC210 (316.5 mg) and 8 (11.2 mg) from TC213 (465.3 mg) were purified by CC on silica gel (60 cm × 2 cm) with hexanes: EtOAc (3:1). (1) 13 
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Assay for the Inhibition of iNOS Activity
The inhibition of iNOS activity was determined in mouse macrophages (RAW264.7) as described earlier [12] [13] .
Reporter Gene Assay for the Inhibition of NF-κB Activity
The assay was performed in human chondrosarcoma (SW1353) cells as described earlier [12] [13] Parthenolide was used as a positive control.
Assay for the Inhibition of Cellular Oxidative Stress
The cellular antioxidant activity was carried out in HepG2 cells according to a method previously described [13] .
Results and Discussion
Chemical investigation of the three different extracts of T. caligatum afforded two new (1 and 2) ( Figure 1 ) and six known (3) (4) (5) (6) (7) (8) compounds. The known compounds were identified as lascivol (3) [14] , trametenolic acid (4) [15] , ergosterol (5) [16] , ergosterol peroxide (6) [2] , 5,6-epoxyergosterol (7) [17] , and cerebroside B (8) [18] . The anti-inflammatory activity ( Table 1) of isolated compounds (1) (2) (3) (4) (5) (6) (7) (8) were tested through a series of cellular assays targeting NAG-1 (NSAIDs-activated gene-1), NF-κB (nuclear transcription factor κB), and iNOS (inducible nitric oxide synthase). The antioxidant potential of the compounds was analysed in terms of decreasing ROS (reactive oxygen species) generation.
Figure 1. Structures of compounds 1-3
Compound 1 was obtained as an amorphous powder, −30 (c 1.0, MeOH) and its molecular formula was determined to be C16H26N2O6 on the basis of the protonated molecule shown in HRESIMS as an ion at m/z 343.1867 (calcd for C16H27N2O6, 343.1869). In the 13 C NMR spectrum totally 14 resonances, corresponding to two methyls (δ 16.0 and 19.6), four methylenes (δ 27.9, 31.6, 31.5, and 26.7), four methines (δ 48.1, 72.8, 80.4, and 54.2), two sp 2 non-protonated carbons (δ 159.6 and 131.7), an oxo group (δ 200.7) and a methoxy group (δ 56.9), were observed. The NMR data of (1) resembled with those of lascivol except for the missing resonances of a methoxy group and carbonyl carbons of acid and amide functions. The molecular weight of 1 is 30 Dalton less than that of lascivol which supported dearth of one methoxy group. The resonances for carbonyl carbons of acid and amide functions in glutamine unit were not observed in 13 C NMR but justified from mass data. In NMR data, the main differences were observed for C-8 and H-8 chemical shifts. Furthermore, the HMBC correlation of H-3 and H-10 with C-8 (δ 31.6) and the COSY correlations of H-2 with H-3, H-8 with H-10 and H-2 with H-7 confirmed that methoxy group at C-8 in lascivol was mislaid in 1 (Figure 2 ). Finally, the structure of 1 was elucidated as a derivative of glutamine and named 8demethoxylascivol ( Figure 1 ).
Figure 1. COSY and HMBC correlations of compounds (1) and (2)
Compound 2 was obtained as an amorphous powder, +28 (c 1.5, MeOH); the molecular formula was determined to be C17H28N2O7 on the basis of the deprotonated molecule shown in HRESIMS as an ion at m/z 371.1830 (calcd for C17H27N2O7, 371.1818). The 13 C NMR and 1 H NMR data exhibited that 2 has a similar structure with lascivol. Taking in consideration the difference in the absolute rotation values between 2 and lascivol −88 (c 1.5, MeOH); and the difference in the chemical shift and coupling constant of H-8 proton of at δ 4.10 (dd, J = 10.1, 5.0 Hz) in contrary to the corresponding proton in lascivol at δ 3.89 (t, J= 3.6 Hz). The large coupling constant suggested the axial orientation for H-8 which was further supported by the NOESY correlation between H-8 (δ 4.10) and H-6 (δ 3.76). The coupling constant values of C-7 methylene protons also supported R configuration at C-8. Thus, the structure of 2 was elucidated as shown in Figure 1 and named as 8-epilascivol.
Compound 3 was obtained as a colourless solid; −88 (c 1.5, MeOH); The molecular formula was determined to be C17H28N2O7 on the basis of a deprotonated molecule shown in HRESIMS as an ion at m/z 371.1830 (calcd for C17H27N2O7, 371.1818). Analysis of 2D-NMR spectroscopic data of 3 revealed that it was a previously reported molecule named lascivol which gives the bitter taste to the mushroom [14] . In contrast to this, L-glutamate derivative provide savoury, tasty or meaty sensation [19] .
Among the new compounds, 8-demethoxylascivol (1) exhibited inhibition of iNOS activity in LPS-induced macrophages with IC50 value of 43.8 µM without causing any toxicity to macrophages. This compound did not show any inhibition of NF-κB and did not cause any decrease in oxidative stress. Moreover, ergosterol (5) and ergosterol peroxide (6) (IC50: 18.9 and 10.5 M, respectively) were more effective than trametenolic acid (4) and 5,6-epoxyergosterol (7) (IC50: 30.7 and 43.7 M, respectively) in inhibiting iNOS. Compounds (4-7) were less potent than parthenolide (IC50 1.7 M). However, ergosterol peroxide (6) showed cytotoxicity towards macrophages at the highest tested concentration of 25 g/mL (80% decrease in cell viability). The increase in transcriptional activity of NF-κB in PMA-treated cells was also not suppressed by these compounds except ergosterol (5) (IC50: 40.4 M). 
